Proactive risk management helps pharma protect their product development investments and future.
News
Advertisement
Industry news focusing on the people and organizations who work in the clinical trials profession.
Advertisement
Three-phase approach to make a midstudy vendor transition less painful.
Advertisement
Findings show big pharma increasingly turning to other companies for molecules to stock its pipeline.
Advertisement
Is ensuring integrity within the clinical trials enterprise, as some claim, beyond the reach of industry?
Info for Authors
Lisa Henderson discusses industry's advice on handling the potentially trial altering occurrence of EDC vendor merges.
A Revolution in Physician Targeting: In-source analytics-driven intelligence to go beyond decile-based targeting - SAS Whitepaper
New Dimensions in EDC/eClinical - TMF and Document Management - ACT Whitepaper
Managed Innovation, Assured Compliance - SAS Apps Note
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026 Keynote Panel: Is Radical Acceleration in Clinical Research Possible?
2
SCOPE Summit 2026 Panel Discussion: Diversity in Clinical Trials—What’s Working, What’s Next
3
Accelerate Clinical Trials with AI-Enhanced Financial Management
4
SCOPE Summit 2026: Reducing Patient Burden Is the Foundation of Wearable Success in Oncology
5